标题
Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors
作者
关键词
-
出版物
Cancers
Volume 11, Issue 10, Pages 1534
出版商
MDPI AG
发表日期
2019-10-11
DOI
10.3390/cancers11101534
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study
- (2019) Konrad Kokowski et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Preparation of highly activated natural killer cells for advanced lung cancer therapy
- (2019) Silun Xie et al. OncoTargets and Therapy
- Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
- (2019) Weilei Hu et al. Frontiers in Immunology
- In vitro cytotoxic effect of Trastuzumab in combination with Pertuzumab in breast cancer cells is improved by interleukin-2 activated NK cells
- (2019) Amir Asgari et al. MOLECULAR BIOLOGY REPORTS
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression
- (2018) Jingjing Cong et al. Cell Metabolism
- Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
- (2018) May Daher et al. CURRENT OPINION IN IMMUNOLOGY
- Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinoma
- (2018) Lingyu Li et al. CYTOTHERAPY
- Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer
- (2018) Takeshi Ishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Predominance of regorafenib over sorafenib: Restoration of membrane-bound MICA in hepatocellular carcinoma cells
- (2018) Jun Arai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia
- (2018) Franco Locatelli et al. TRENDS IN IMMUNOLOGY
- Natural killer cells inhibit metastasis of ovarian carcinoma cells and show therapeutic effects in a murine model of ovarian cancer
- (2018) Yanming Sun et al. Experimental and Therapeutic Medicine
- Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives
- (2018) Stanislaw Schmidt et al. Oncotarget
- Expanded CD56superbrightCD16+ NK cells from ovarian cancer patients are cytotoxic against autologous tumor in a patient-derived xenograft murine model
- (2018) Sophie M Poznanski et al. Cancer Immunology Research
- High-Risk Leukemia: Past, Present, and Future Role of NK Cells
- (2018) Melissa Mavers et al. Journal of Immunology Research
- Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
- (2018) Shakeel Modak et al. OncoImmunology
- Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugs
- (2018) Kawaljit Kaur et al. OncoImmunology
- Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
- (2018) Faezeh Hosseinzadeh et al. Cancer Cell International
- Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver Cancer
- (2018) Yumei Yang et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome
- (2018) Mohammed Alnaggar et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
- (2018) Estefanía Paula Juliá et al. Frontiers in Immunology
- Challenges of NK cell-based immunotherapy in the new era
- (2018) Fang Fang et al. Frontiers of Medicine
- Shining light on the significance of NK cell CD56 brightness
- (2018) Sophie M. Poznanski et al. Cellular & Molecular Immunology
- The rise of human stem cell-derived natural killer cells for cancer immunotherapy
- (2018) Kejian Wang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection
- (2018) Anita Schuch et al. JOURNAL OF HEPATOLOGY
- Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of “senescent” NK cells to lose CD57 expression and start expressing NKG2A
- (2018) Maria A. Streltsova et al. PLoS One
- Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer
- (2018) Neelam Mukherjee et al. Oncotarget
- Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
- (2018) Qing Zhang et al. Journal of Immunology Research
- Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy
- (2017) Gilles Jobin et al. GASTROENTEROLOGY
- Missing or altered self: human NK cell receptors that recognize HLA-C
- (2017) Hugo G. Hilton et al. IMMUNOGENETICS
- NK cell-based immunotherapy for cancer
- (2017) Fang Fang et al. SEMINARS IN IMMUNOLOGY
- Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer
- (2017) Shuzhen Liang et al. OncoTargets and Therapy
- Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer
- (2017) Jongmi Lee et al. Oncotarget
- The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
- (2017) John P. Veluchamy et al. Frontiers in Immunology
- Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients
- (2017) Kawaljit Kaur et al. Frontiers in Immunology
- Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice
- (2016) Anna K. Kozlowska et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
- (2016) Jesus I. Luna et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
- (2016) Andreas T. Björklund et al. JOURNAL OF IMMUNOLOGY
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
- (2016) Y. Yang et al. Cancer Immunology Research
- Natural killer cell immunotherapy to target stem-like tumor cells
- (2016) Steven K. Grossenbacher et al. Journal for ImmunoTherapy of Cancer
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing +T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies
- (2015) L. Muccio et al. HAEMATOLOGICA
- Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
- (2015) Naoyuki Sakamoto et al. Journal of Translational Medicine
- CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT
- (2015) F Cichocki et al. LEUKEMIA
- Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing +T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies
- (2015) L. Muccio et al. HAEMATOLOGICA
- A high-throughput assay of NK cell activity in whole blood and its clinical application
- (2014) Saet-byul Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Reduction of the CD16−CD56bright NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer
- (2013) Kyo Chul Koo et al. PLoS One
- Impact of HCMV Infection on NK Cell Development and Function after HSCT
- (2013) Mariella Della Chiesa et al. Frontiers in Immunology
- Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
- (2012) M Stern et al. BONE MARROW TRANSPLANTATION
- Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors
- (2012) W. Jiang et al. GENOME RESEARCH
- Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity
- (2012) Jennifer T. Grier et al. JOURNAL OF CLINICAL INVESTIGATION
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
- (2011) B. Foley et al. BLOOD
- Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
- (2011) M. R. Parkhurst et al. CLINICAL CANCER RESEARCH
- IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study
- (2011) Claudia Brehm et al. PLoS One
- Ex vivo Expansion of CD56+ NK and NKT-like Lymphocytes from Peripheral Blood Mononuclear Cells of Patients with Ovarian Neoplasia
- (2011) P. C. M. Alves et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
- (2010) Eleni G. Iliopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Different Patterns of Evolution in the Centromeric and Telomeric Regions of Group A and B Haplotypes of the Human Killer Cell Ig-Like Receptor Locus
- (2010) Chul-Woo Pyo et al. PLoS One
- Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study
- (2009) S R Yoon et al. BONE MARROW TRANSPLANTATION
- Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9
- (2009) Keisuke Kohga et al. HEPATOLOGY
- Safety analysis ofex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
- (2009) Lisbeth Barkholt et al. Immunotherapy
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More